GSK-3β: A key regulator of breast cancer drug resistance

Por Martelli, Alberto M, Buontempo, Francesca, Evangelisti, Camilla
Publicado em 2014

Contact dermatitis in children

Por Pigatto, Paolo, Martelli, Alberto, Marsili, Chiara, Fiocchi, Alessandro
Publicado em 2010

The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients

Por Martelli, Alberto M., Evangelisti, Camilla, Chiarini, Francesca, McCubrey, James A.
Publicado em 2010

Exploiting p53 Status to Enhance Effectiveness of Chemotherapy by Lowering Associated Toxicity

Por Steelman, Linda S., Martelli, Alberto M., Nicoletti, Ferdinando, McCubrey, James A.
Publicado em 2011

Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients

Por Martelli, Alberto M., Lonetti, Annalisa, Amadori, Sergio, McCubrey, James A., Chiarini, Francesca
Publicado em 2013

The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated...

Por Cappellini, Alessandra, Chiarini, Francesca, Ognibene, Andrea, McCubrey, James A., Martelli, Alberto M.
Publicado em 2009

The Emerging Role of the Phosphatidylinositol 3-Kinase/ Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology

Por Martelli, Alberto M., Evangelisti, Camilla, Chiarini, Francesca, Grimaldi, Cecilia, McCubrey, James A.
Publicado em 2010

Differential diagnosis of food protein-induced enterocolitis syndrome

Por Fiocchi, Alessandro, Claps, Alessia, Dahdah, Lamia, Brindisi, Giulia, Dionisi-Vici, Carlo, Martelli, Alberto
Publicado em 2014

DRACMA one year after: Which changes have occurred in diagnosis and treatment of CMA in Italy?

Por Fiocchi Alessandro, Schunemann Holger, Terracciano Luigi, Albarini Marco, Martelli Alberto, Landi Massimo, Compalati Enrico, Canonica Giorgio
Publicado em 2011-11-01

Proliferating or Differentiating Stimuli Act on Different Lipid-dependent Signaling Pathways in Nuclei of Human Leukemia Cells

Por Neri, Luca M., Bortul, Roberta, Borgatti, Paola, Tabellini, Giovanna, Baldini, Giovanna, Capitani, Silvano, Martelli, Alberto M.
Publicado em 2002

DRACMA one year after: Which changes have occurred in diagnosis and treatment of CMA in Italy?

Por Fiocchi, Alessandro, Schunemann, Holger, Terracciano, Luigi, Albarini, Marco, Martelli, Alberto, Landi, Massimo, Compalati, Enrico, Canonica, Giorgio Walter
Publicado em 2011

Expression of Rab3D N135I Inhibits Regulated Secretion of ACTH in AtT-20 Cells

Por Baldini, Giulia, Baldini, Giovanna, Wang, Guangyi, Weber, Mattew, Zweyer, Marina, Bareggi, Renato, Witkin, Joan W., Martelli, Alberto M.
Publicado em 1998

The therapeutic potential of mTOR inhibitors in breast cancer

Por Steelman, Linda S., Martelli, Alberto M., Cocco, Lucio, Libra, Massimo, Nicoletti, Ferdinando, Abrams, Stephen L., McCubrey, James A.
Publicado no Br J Clin Pharmacol (2016)

Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment

Por Martelli, Alberto M., Chiarini, Francesca, Evangelisti, Camilla, Cappellini, Alessandra, Buontempo, Francesca, Bressanin, Daniela, Fini, Milena, McCubrey, James A.
Publicado em 2012

The AKT Inhibitor MK-2206 is Cytotoxic in Hepatocarcinoma Cells Displaying Hyperphosphorylated AKT-1 and Synergizes with Conventional Chemotherapy

Por Simioni, Carolina, Martelli, Alberto M., Cani, Alice, Cetin-Atalay, Rengul, McCubrey, James A., Capitani, Silvano, Neri, Luca M.
Publicado em 2013

Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation

Por Simioni, Carolina, Cani, Alice, Martelli, Alberto M., Zauli, Giorgio, Tabellini, Giovanna, McCubrey, James, Capitani, Silvano, Neri, Luca M.
Publicado no Oncotarget (2014)

Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia

Por Simioni, Carolina, Ultimo, Simona, Martelli, Alberto M., Zauli, Giorgio, Milani, Daniela, McCubrey, James A., Capitani, Silvano, Neri, Luca M.
Publicado no Oncotarget (2016)

PKR Regulates B56α-mediated BCL2 Phosphatase Activity in Acute Lymphoblastic Leukemia-derived REH Cells

Por Ruvolo, Vivian R., Kurinna, Svitlana M., Karanjeet, Kul B., Schuster, Todd F., Martelli, Alberto M., McCubrey, James A., Ruvolo, Peter P.
Publicado em 2008

DUAL INHIBITION OF CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE AND mTOR AS A NEW THERAPEUTIC OPTION FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Por Chiarini, Francesca, Falà, Federica, Tazzari, Pier Luigi, Ricci, Francesca, Astolfi, Annalisa, Pession, Andrea, Pagliaro, Pasqualepaolo, McCubrey, James A., Martelli, Alberto M.
Publicado em 2009

Nutritional management and follow up of infants and children with food allergy: Italian Society of Pediatric Nutrition/Italian Society of Pediatric Allergy and Immunology Task Forc...

Por Giovannini, Marcello, D'Auria, Enza, Caffarelli, Carlo, Verduci, Elvira, Barberi, Salvatore, Indinnimeo, Luciana, Iacono, Iride Dello, Martelli, Alberto, Riva, Enrica, Bernardini, Roberto
Publicado em 2014